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ERWIN H. ZIMMERMAN, M.C., U. S. ARMY
The silicones consist of molecular chains of alternate oxygen and silicone atoms
and differ from ordinary organic compounds in that certain carbon atoms are
replaced by silicon atoms (1).
The silicones are chemically inert and possess water repellent and adhesive
properties. Their physical properties are unusually independent of extremes in
temperature. They have been used as lubricants, insulators, in weather resistant
paints and in the treatment of fabrics to render them water repellent, to mention
but a few of their many uses. More recently the siicones have been incorporated
in various ointment bases and used as skin protectants. A recent report (2) on
the clinical evaluation of such a preparation states that 30% silicone oils in a
petrolatum base proved beneficial in 58 of 61 dermatologic conditions.
The present report is an evaluation of a special plasticized combination of
silicone (dimethylpolysiloxane), nitrocellulose and castor oil suspended in a
greaseless vanishing cream base. t
PRELIMINARY STUDY
In a preliminary evaluation of this product, 21 subjects were skin tested in
the manner outlined below, with the one exception that orthodox patch tests
were used instead of the open skin test method. Little or no protective efficiency
was demonstrated. In fact, in a few of the subjects, the patch test response was
greater at the sites prepared with the silicone cream than on an anatomically
symmetrical site not so protected. These findings were not unlike those of Mad-
sen (3) who made an evaluation of a new protective cream known as Kerodex
by means of the patch test method.
In the opinion of the writers the patch test is not a satisfactory method of
studying the protective efficiency of a protective cream. The prolonged close
contact, occlusion, maceration, heating and friction are greatly at variance with
the true conditions of usual clinical exposures to most eczematogenous allergens.
It was felt that the open skin test method would more nearly simulate actual
clinical contact with the allergenic substance; and that a cream's protective
efficiency, if any, could be more readily demonstrated by this means.
* From the Department of Dermatology and Syphilology of the New York University
Post-Graduate Medical School (Dr. Marion B. Sulzberger, Chairman), and the Skin &
Cancer Unit of the University Hospital.
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METHOD
Measurement of the quantity of cream required to inunct a given area of the body. In order
to be certain that the test subjects applied an amount of cream adequate to entirely cover
the test site or sites, it was necessary to predetermine the amount of cream necessary by
applying quantities of the creams to selected areas on two of the participants. By expressing
measured amounts of the cream from the tube in which the cream is supplied, the following
quantities were found necessary to cover the stated areas: a) for one-half of the upper back
(from midline to posterior axillary line and from shoulder to waist), 2.5 inches of cream as
expressed from the tube; b) for the lateral aspect of the thigh (from midline of anterior
aspect to midline of posterior aspect and from knee to greater trochanter), 2.0 inches of
cream as expressed from tube; c) for the anterior aspect of arm (from midline of medial
aspect to midline of lateral aspect and from antecubital fossa to shoulder) 1.5 inches of
cream as expressed from tube.
Belection of subjects. Subjects were selected from the patients seen in the allergy section
of the Skin and Cancer Unit. These subjects were selected on the basis of having previously
shown a positive reaction to the standard concentration (4) of one of a variety of commonly
encountered eczematogenous contact allergens. Selection was also made according to the
cooperativeness and intelligence of the patient in regard to proper inunction of the cream.
Preparation of test sites. Detailed directions for the method and frequency of application
of the creams were mimeographed for distribution to the test subjects. The subjects were
instructed to thoroughly inunct the designated amount of the protective cream on the se-
lected test site, twice daily. They were instructed to bathe as usual and return for skin
testing in a given number of days (2 to 18 days). The selection of actual test sites depended
on several factors: a) the number of tests to be applied, b) areas most suitable to the sub-
jects as well as the testers, c) areas of greatest ease of inunction. In each case an ana-
tomically symmetrical site, on which no protective cream had been inuncted, was used for
a comparative series of tests.
Method of testing. After the subjects completed the inunction for the specified length of
time, a series of skin tests was applied, using graded dilutions of the allergens to both the
prepared site and the contralateral unprepared site. The open skin test method was em-
ployed. The various dilutions of the allergens were painted on an area approximately 2 x 2
centimeters. The site of each skin test was previously outlined by a skin marking pencil.
All allergens were incorporated into liquid vehicles. With a few exceptions the tests were
read in 48 hours.
Comparison and evaluation of the results. By comparing the skin test reactions on the pre-
pared site with those on the unprepared contralateral site, it was ascertained whether the
silicone cream offered any protection, and if so, to what degree. The results of the skin test
are recorded according to a modified Bloch Classification.*
Method for comparison of the protective efficiency of silicone cream with several
other skin protectant creams and ointments. After ascertaining the end points of
the skin test reactions in the preceding tests, several dilutions of the allergen
above and below the end points, were used to compare the protective efficiency
of silicone cream with other available preparations. Tests were applied after a
single application of silicone cream and the other protective cream selected for
*
— No reaction.
(+) Faint erythema.
+ Definite erythema.
++ Erythema, edema and beginning papule and/or vesicle formation.
+++ Papule and vesicle formation, erythema and infiltration or bullae.
++++ Large confluent bullae, erythema and edema, or denudation and necrosis.
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the comparison. Where end point determinations were performed on the back,
the comparative study with the other protective cream was performed on the
thighs and vice versa. Anatomically symmetrical sites were selected for the com-
parison. After each cream was thoroughly inuncted, one-half of each inuncted
site was washed with lukewarm water. Identical dilutions of the allergen, using
the open skin test method, were applied to a washed and unwashed site on each
selected area. The tests were read in 48 hours.
RESULTS
Thirty six subjects (Table I) with known allergic eczematous contact sensi-
tivities were tested by the open skin test method using graded dilutions of the
allergens. One series of the tests was applied to a site previously prepared by
inuncting with a silicone cream. Another series of the tests was applied to an
anatomically symmetrical site not inuncted. With two exceptions,* the tests
were read in 48 hours. Thirty of the thirty-six subjects demonstrated protection
in varying degrees on the silicone cream inuncted site as compared to the unpre-
pared site. In five subjects there was no difference in the skin test reactions be-
tween the prepared site and the unprepared site on the contralateral side. It is
possible that in these five cases also, bad the dilutions of the allergens been
graded to a finer degree, some protection could have been demonstrated. In
one subject the skin test response was greater on the prepared site as com-
pared to the unprepared site.
Generally speaking, the greater the number of days the silicone cream was
applied prior to testing, the greater was its protective efficiency.
As demonstrated in Table II, the silicone cream was compared with three
other skin protectant preparations, both before and after washing. Preparations
A and B are commercially available preparations that do not contain silicone.
Preparation C is a purchasable silicone-containing ointment with a petrolatum
base. The silicone cream under study in the above mentioned experiment (Covi-
cone-Abbott) was found superior in protective efficiency to preparations A and
B both before and after washing (Cases 1, 3, 7, 8 and 11). Preparation C was
found to protect slightly more than Covicone in two of the three cases tested
when the sites of the protective preparations were not washed before testing,
(Cases 9, 10 and 25). However preparation C was slightly less protective than
Covicone in all three cases when the sites of the protective preparations were
washed before testing.
As a skin protectant, Covicone has all the obvious advantages of a greaseless
vanishing cream base plus protective efficiency before and after washing. It is
colorless when applied to the skin.
No allergic sensitivities to Covicone were encountered during the course of
this study. However, in two cases being prepared for testing during the summer
months, a pustular eruption, due probably to an occlusion of the sweat and/or
the sebaceous ducts, developed and was confined to the sites of application.
* See Table I.
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Case 17
FIG. 1. Demonstrating the degree of protection with Covicone 96 hours after applying
graded dilutions (acetone) of oleoresin from toxicodendron (poison ivy). (Color ptGte
Courtesy Abbott Laboretories, North Chicago, Illinois)
j
fr 1—10
1—40
1—100
1—500
1—
1—4
TA
BL
E I
I 
A
lle
rg
ic
 ak
in
 r
ea
ct
io
ns
 to
 o
pe
n 
te
st
s 
o
bt
ai
ne
d 
in
 ex
pe
rim
en
ta
l 
co
m
pa
ris
on
 o
f t
he
 p
ro
te
ct
iv
e 
ef
fic
ie
nc
y o
f C
ov
ic
on
e W
ith
 th
re
e 
o
th
er
 s
ki
n p
ro
te
ct
an
ts 
CA
SE
 
N
O
. 
D
IL
U
TI
O
N
S 
O
P 
A
LL
ER
G
EN
S 
1—
10
 
1—
20
 
1-
40
 
1—
10
 
1—
10
0 
1—
20
0 
1—
40
0 
1—
60
0 
1—
80
0 
1—
1.
00
0 
1—
5,
00
0 
1—
10
.0
00
 
1—
10
0,
00
0 
11
 
N
.W
. 
Cc
 
A
 
Cc
 
A
 
(+
) 
+
 
-
 
+
 
-
 
+
 
-
 (+)
 
W
. 
+
 
+
 
(+
) 
+
 
(+
) + 
(+
) 
(+
) 
7 
N
.W
. 
Cc
 
A
 
—
 
Cc
 
A
 
(+
) 
+
 
-
 
-
 
-
 
-
 
-
 
-
 
W
. 
(+
) 
+
+
 
—
 
+
 
—
 
+
 
—
 (+)
 
3 
N
.W
. 
Cc
 
A
 
—
 
Cc
 
A
 
(+
) + 
(+
) 
+
 
(+
) 
+
 
—
 (+)
 
—
 (+)
 
—
 (+)
 
W
. 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
+
 
(+
) 
+
 
-
 
-
 
8 
N
.W
. 
Cc
 
B
 
—
 
Cc
 
B
 
+
+
+
 
+
+
+
 
+
 
+
+
 
-
 
+
+
 
-
 
-
 
W
. 
+
+
+
 
+
+
+
 
+
+
 
+
+
+
 
-
 
+
+
 
-
 
-
 
1 
N
.W
. 
Cc
 
B
 
—
 
Cc
 
B
 
-
 
+
 
+
 
+
 
1-
 
W
. 
—
 (+)
 
—
 (+)
 
(+)
 
(+
) 
—
 (+)
 
C.
' 0 I 
0 z O 
10
 
N
.W
. 
Cc
 
C 
—
 
Cc
 
C 
+
+
 
+
+
 
+
 
(+
) 
+
 
(+
) 
-
 
-
 
-
 
-
 
-
 
-
 
—
 
-
 
-
 
-
 
W
. 
+
+
 
+
+
 
+
 
(+
) 
+
 
(+
) 
(+
) 
(+
) 
(+
) 
(+
) 
-
 (+)
 
-
 (+)
 
—
 
—
 
25
 
N
.W
.C
c C 
—
 
Co
 
C 
—
 
—
 
—
 
—
 
—
 
—
 
W
. 
—
 +
 
—
 
—
 
—
 
—
 
N
.W
. 
Cc
 
C 
9 
+
 
(+
) 
-
 
(+)
 
-
 
-
 
N
. W
. 
n
o
t w
as
he
d.
 
W
. 
w
as
he
d.
 
Cc
 =
 
Co
vic
on
e.
 
A
, B
, C
 
th
re
e 
di
ffe
re
nt
 pr
ot
ec
tiv
e c
re
am
s.
 
W
. 
Cc
 
C 
+
 
+
 
+
 
+
 
(+
) + 
(+
) 
+
 
(+
) + 
—
 
-
 
—
 
-
 
120 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Although detailed clinical evaluation of Covicone in actual use was not at-
tempted in this study, our results to date have been encouraging in a variety of
dermatologic conditions, including diaper rash and as an interval protectant in
chronic and chronic recurrent eczematous eruptions of the hands.
CONCLUSIONS
Using graded dilutions of a variety of commonly encountered allergens and
employing the open skin test method, varying degrees of protection were demon-
strated in 30 of 36 subjects who had previously prepared test sites with Covi-
cone.
In comparing Covicone with three other skin protectant preparations, Covi-
cone was found superior to all three when the sites of application of the protective
creams were washed before applying the skin tests. Covicone was also found
superior to two of the three preparations, to which it was compared when the
sites of application of the protective preparations were not washed prior to
testing.
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